PARP16
Basic information
Region (hg38): 15:65234460-65300618
Previous symbols: [ "C15orf30" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PARP16 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 29 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 29 | 0 | 1 |
Variants in PARP16
This is a list of pathogenic ClinVar variants found in the PARP16 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-65259416-C-T | Benign (Apr 06, 2018) | |||
15-65259459-C-T | not specified | Uncertain significance (Oct 10, 2023) | ||
15-65260892-G-C | not specified | Uncertain significance (Dec 10, 2024) | ||
15-65260904-A-C | not specified | Uncertain significance (Sep 26, 2024) | ||
15-65260907-A-T | not specified | Uncertain significance (Nov 15, 2024) | ||
15-65260969-A-T | not specified | Uncertain significance (Mar 08, 2025) | ||
15-65260975-C-T | not specified | Uncertain significance (Apr 20, 2023) | ||
15-65261002-C-T | not specified | Uncertain significance (Jan 19, 2025) | ||
15-65263170-T-G | not specified | Uncertain significance (Aug 05, 2024) | ||
15-65263178-G-A | not specified | Uncertain significance (May 24, 2023) | ||
15-65263188-T-C | not specified | Uncertain significance (Jul 20, 2021) | ||
15-65263194-C-T | not specified | Uncertain significance (Apr 01, 2024) | ||
15-65263200-C-T | not specified | Uncertain significance (Feb 08, 2023) | ||
15-65263224-C-T | not specified | Uncertain significance (Dec 02, 2022) | ||
15-65263248-G-A | not specified | Uncertain significance (Nov 19, 2022) | ||
15-65263269-G-C | not specified | Uncertain significance (Jul 13, 2021) | ||
15-65263299-T-C | not specified | Uncertain significance (Dec 02, 2022) | ||
15-65263316-G-A | not specified | Uncertain significance (Oct 12, 2022) | ||
15-65266577-G-C | not specified | Uncertain significance (Dec 03, 2021) | ||
15-65266587-T-C | not specified | Uncertain significance (Sep 14, 2021) | ||
15-65266647-C-T | not specified | Uncertain significance (Mar 07, 2025) | ||
15-65266668-A-G | not specified | Uncertain significance (Nov 07, 2022) | ||
15-65266681-C-G | not specified | Uncertain significance (Sep 26, 2024) | ||
15-65270957-A-G | not specified | Uncertain significance (Apr 12, 2023) | ||
15-65271039-C-G | not specified | Uncertain significance (Jul 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PARP16 | protein_coding | protein_coding | ENST00000261888 | 6 | 66159 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.99e-10 | 0.0868 | 125703 | 0 | 45 | 125748 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.367 | 167 | 181 | 0.923 | 0.00000961 | 2101 |
Missense in Polyphen | 54 | 56.39 | 0.95762 | 628 | ||
Synonymous | 0.0142 | 77 | 77.2 | 0.998 | 0.00000435 | 635 |
Loss of Function | 0.139 | 15 | 15.6 | 0.962 | 9.44e-7 | 164 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000496 | 0.000496 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.000106 | 0.000105 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Intracellular mono-ADP-ribosyltransferase that may play a role in different processes through the mono-ADP-ribosylation of proteins involved in those processes (PubMed:23103912, PubMed:22701565). May play a role in the unfolded protein response (UPR), by ADP-ribosylating and activating EIF2AK3 and ERN1, two important UPR effectors (PubMed:23103912). May also mediate mono- ADP-ribosylation of karyopherin KPNB1 a nuclear import factor (PubMed:22701565). May not modify proteins on arginine, cysteine or glutamate residues compared to other mono-ADP- ribosyltransferases (PubMed:22701565). {ECO:0000269|PubMed:22701565, ECO:0000269|PubMed:23103912}.;
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.830
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.91
Haploinsufficiency Scores
- pHI
- 0.234
- hipred
- N
- hipred_score
- 0.350
- ghis
- 0.563
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.652
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Parp16
- Phenotype
Gene ontology
- Biological process
- protein ADP-ribosylation;endoplasmic reticulum unfolded protein response;NAD biosynthesis via nicotinamide riboside salvage pathway;IRE1-mediated unfolded protein response;negative regulation of cell death;protein auto-ADP-ribosylation;positive regulation of protein serine/threonine kinase activity;cellular response to leukemia inhibitory factor
- Cellular component
- nuclear envelope;endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;membrane;integral component of membrane;endoplasmic reticulum tubular network
- Molecular function
- NAD+ ADP-ribosyltransferase activity;protein binding;kinase binding;protein serine/threonine kinase activator activity